REVELSTOKE CAPITAL MANAGEMENT LLC


A. Describe your advisory firm, including how long you have been in business. Identify
your principal owner(s).
Revelstoke Capital Management, LLC (together with its fund general partners, managers, and relying adviser (unless the context otherwise requires), “Revelstoke” or the “Firm”) is a Denver, Colorado- based investment adviser founded in July 2013. Revelstoke focuses its investments in the healthcare and related business services sectors. The Firm provides portfolio management services to the following private funds: Revelstoke Capital Partners Fund I, L.P. (“Fund I”), Revelstoke Capital Partners Co-Investment Fund I, L.P. (“Fund I Co-Invest”), Revelstoke Single Asset Fund I, L.P. (“SAF”) and Revelstoke Capital Partners Fund II, L.P. (“Fund II” and together with SAF, Fund I and the Fund I Co-Invest, “the Funds”); employee and affiliate pooled investment vehicles (“Affiliate Funds”); and pooled investment vehicles organized for investments in individual portfolio companies to invest alongside a Fund (“Co-Investment Funds,”) (together SAF, Fund I, Fund I Co-Invest, Fund II, Affiliate Funds and Co-Investment Funds are collectively referred to as “Clients”). Each Client is affiliated with a general partner (“General Partner”), manager (“Manager”) and/or Revelstoke Capital Advisors LLC (the “relying adviser”) with authority to make investment decisions on behalf of the applicable Client. The General Partners, Managers and relying adviser are deemed to be registered under the Investment Advisers Act of 1940, as amended (“Advisers Act”) pursuant to Revelstoke’s registration in accordance with SEC guidance. While the General Partners and Managers maintain ultimate authority over the respective Clients, Revelstoke has been designated the role of investment adviser. For more information about the Funds, General Partners, Managers, and relying adviser, please see Revelstoke’s Form ADV Part 1, Schedule D, Sections 7.A. and 7.B.(1). Revelstoke is controlled by Simon A. Bachleda (Managing Partner), Russell J. Cassella (Managing Partner) and Dale J. Meyer (Partner – Investor Relations). The Firm is owned by Revelstoke, L.P. and indirectly by Messrs. Bachleda, Cassella and Meyer. For more information about Revelstoke’s owners and executive officers, see Revelstoke’s Form ADV Part 1, Schedules A, B and R.
B. Describe the types of advisory services you offer. If you hold yourself out as
specializing in a particular type of advisory service, such as financial planning, quantitative
analysis, or market timing, explain the nature of that service in greater detail. If you provide
investment advice only with respect to limited types of investments, explain the type of
investment advice you offer, and disclose that your advice is limited to those types of
investments.
Revelstoke is a private equity firm that focuses on making control equity investments in U.S. middle market companies primarily in the healthcare and related business services sectors. The Firm is responsible for day-to-day management and oversight of the portfolio company investments held by its Clients, with an objective to generate appropriate returns on a risk adjusted basis; however, no assurance can be given that this objective will be met. Revelstoke’s investment advisory services consist of identifying and evaluating investment opportunities, negotiating investments, managing and monitoring investments and achieving dispositions for such investments. Investments are made predominantly in non-public portfolio companies, although investments in public portfolio companies are permitted in certain instances. Where such investments consist of portfolio companies, the senior principals or other personnel and/or third parties appointed by Revelstoke or its affiliates will generally serve on such portfolio companies’ respective boards of directors or otherwise act to influence control over the management of portfolio companies held by the Firm’s Clients.
C. Explain whether (and, if so, how) you tailor your advisory services to the individual
needs of clients. Explain whether clients may impose restrictions on investing in certain
securities or types of securities.
Revelstoke does not tailor its advisory services to the individual needs of investors in its Clients, but rather to the investment objectives and investment strategy of each Client. These objectives are described in the applicable private placement memorandum, limited partnership agreements, limited liability company agreements, investment advisory agreements, side letters and other governing documents of the Clients (collectively, “Governing Documents”). Revelstoke does not require, nor does it seek, approval from its investors with respect to investment decisions for the Clients. Investors in the Clients generally cannot impose restrictions on investing in certain securities or types of securities, other than through side letter agreements. Investors participate in the overall investment program for the applicable Client(s) and generally cannot be excused from a particular investment except pursuant to the terms of the applicable Governing Documents. Revelstoke has entered into side letters or similar agreements with certain investors including those who make substantial commitments of capital or were early-stage investors in the Clients, or for other reasons in the sole discretion of Revelstoke, in each case that have the effect of establishing rights under or altering or supplementing the terms of the applicable Client’s Governing Documents. Examples of such rights include information rights, certain fee arrangements or other economic provisions, transfer rights and “most favored nation” provisions, among others. Revelstoke generally enters into side letters only with investors who make substantial commitments of capital, but reserves the right do so or for other reasons in its sole discretion. Such side letters are typically negotiated at the time of the relevant investor’s capital commitment and once an investor is accepted into a Client, such investor generally cannot impose additional investment guidelines or restrictions on such Client.
D. If you participate in wrap fee programs by providing portfolio management services,
(1) describe the differences, if any, between how you manage wrap fee accounts and how you
manage other accounts, and (2) explain that you receive a portion of the wrap fee for your
services.
Revelstoke does not participate in wrap fee programs.
E. If you manage client assets, disclose the amount of client assets you manage on a
discretionary basis and the amount of client assets you manage on a non-discretionary basis.
Disclose the date “as of” which you calculated the amounts.
As of December 10, 2019, Revelstoke managed $2,275,979,172 of regulatory assets under management, all on a discretionary basis on behalf of its Clients. The calculation of regulatory assets under management includes the duplication of assets to the extent that certain Funds are invested in other Funds. Without such duplication of assets, Revelstoke’s regulatory assets under management is $2,171,159,427. please register to get more info

Open Brochure from SEC website

Related news

Revelstoke completes sale of ONsite Mammography to Olympus Partners

Three-plus years into its investment, Revelstoke Capital Partners has completed the sale of ONsite Mammography to Olympus Partners. ONsite provides comprehensive, in-office imaging solutions to ...

Revelstoke Completes Sale of ONsite Mammography

DENVER, Dec. 29, 2020 /PRNewswire/ -- Revelstoke Capital Partners ("Revelstoke"), a Denver-based private equity firm, announced today that it has completed the sale of ONsite Mammography ("ONsite ...

Revelstoke Capital Partners Raises Single Asset Fund Dedicated to Rural Healthcare

2020 /PRNewswire/ -- Revelstoke Capital Partners ("Revelstoke" or the "Firm"), a leading private equity firm focused on investing in healthcare services companies, announced today that it has completed fundraising for Revelstoke Single Asset Fund II ...

Revelstoke Capital Partners Raises Single Asset Fund Dedicated to Rural Healthcare

DENVER, Dec. 22, 2020 /PRNewswire/ -- Revelstoke Capital Partners ("Revelstoke" or the "Firm"), a leading private equity firm focused on investing in healthcare services companies, announced ...

DataLink Acquires Orizon360°: Expands Value-based Clinical Data Integration, Advanced Analytics and Financial Informatics Capabilities

The Orizon360° acquisition was supported by lead investor Revelstoke Capital Partners. Founded in 2008, Orizon360° is a healthcare data integration and financial informatics company that ...
Loading...
No recent news were found.